Cerity Partners’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Cerity Partners’s Portfolio TLSIW Stock Details TLSIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$993K	Hold	827,590	–	–	﹤0.01%	1867
2025 Q4	$1.37M	Buy	+827,590	New	+$1.05M	﹤0.01%	1554

Other funds holding TLSIW

Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

FBCM

Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Cerity Partners's TLSIW Position: Q1 2026 in Review

Cerity Partners held its TriSalus Life Sciences Warrant (TLSIW) position steady in Q1 2026 at 827,590 shares worth $993K. The position accounts for ﹤0.01% of the portfolio, ranked #1867.

Cerity Partners first reported a position in TLSIW in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.37M in Q4 2025. 7 funds tracked by Wall St. Rank hold TLSIW as of Q1 2026.

Cerity Partners held 827,590 shares of TriSalus Life Sciences Warrant worth $993K as of Q1 2026.
Cerity Partners left its TriSalus Life Sciences Warrant share count unchanged in Q1 2026.
TriSalus Life Sciences Warrant made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #1867 holding.
Cerity Partners first reported a position in TriSalus Life Sciences Warrant in Q4 2025 and has held it in 2 quarters since.
Cerity Partners's TriSalus Life Sciences Warrant position peaked at $1.37M in Q4 2025.
7 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.